Evidence map›Paper›PMID 36051469›Full record

ReviewThe breast journal2022

Differences of Clinicopathological Features between Metaplastic Breast Carcinoma and Nonspecific Invasive Breast Carcinoma and Prognostic Profile of Metaplastic Breast Carcinoma.

Yue Qiu, Yuhui Chen, Li Zhu, Hongye Chen, Yongjing Dai, Baoshi Bao, Lin Tian, Xiaopeng Hao, Jiandong Wang

Open access · goldAbstract readReview
In one paragraph

Review in The breast journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yue QiuChinese PLA Medical School, Beijing 100853, China.ORCID 0000-0001-9800-711X
Yuhui ChenDepartment of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.ORCID 0000-0002-4148-3729
Li ZhuDepartment of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.ORCID 0000-0002-6138-7216
Hongye ChenDepartment of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.ORCID 0000-0001-5774-1705
Yongjing DaiDepartment of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.ORCID 0000-0001-7408-2932
Baoshi BaoDepartment of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.ORCID 0000-0002-7263-4120
Lin TianDepartment of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.ORCID 0000-0002-8449-3847
Xiaopeng HaoDepartment of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.ORCID 0000-0002-0736-8962
Jiandong WangDepartment of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.ORCID 0000-0003-0414-3802
Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Metaplastic breast carcinoma is a rare special type of breast cancer, which has distinguished clinical characteristics. We aimed to evaluate the clinicopathological features of metaplastic breast carcinoma compared with nonspecific invasive breast carcinoma and study the prognosis of metaplastic breast carcinoma. Methods: We reviewed metaplastic breast carcinoma cases ( Results: Patients with metaplastic breast carcinoma had more advanced disease than patients with nonspecific invasive breast carcinoma (T stage: Conclusion: The majority of metaplastic breast carcinoma patients had more advanced disease and triple-negative disease than nonspecific invasive breast carcinoma patients. Also, metaplastic breast carcinoma patients had frequent skin or chest wall invasion and a high rate of distant metastasis and mortality.

Indexed as

Breast NeoplasmsCarcinoma, Ductal, BreastTriple Negative Breast NeoplasmsBiomarkers, TumorErb-b2 Receptor Tyrosine KinasesFemaleHumansMetaplasiaPrognosisRetrospective StudiesBiomarkers, TumorErb-b2 Receptor Tyrosine Kinases

Identifiers

PMID36051469
PMCPMC9424033
OpenAlexW4293254663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.